Cover image for The nidoviruses : toward control of SARS and other nidovirus diseases
Title:
The nidoviruses : toward control of SARS and other nidovirus diseases
Series:
Advances in experimental medicine and biology ; 581
Publication Information:
Iowa City, IA : Springer, 2006
ISBN:
9780387262024
General Note:
Also available online version
Electronic Access:
Full Text

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010124852 QR395 N52 2006 Open Access Book Proceedings, Conference, Workshop etc.
Searching...

On Order

Summary

Summary

This book summarizes the keynote and plenary speeches and posters of the Xth International Nidovirus Symposium: Toward Control of SARS and Other Nidovirus Diseases" that was held in Colorado Springs, Colorado, June 25-30, 2005. The nine previous meetings of scientists investigating the molecular biology and pathogenesis of coronaviruses, toroviruses, arteriviruses, and okaviruses were generally held every 3 years since the first meeting was convened in Wurzburg, Germany, in October, 1980. The Xth International Symposium was held just 2 years after the IXth International Symposium (Nido2003) in The Netherlands, because of the tremendously increased research on nidoviruses that resulted from the discovery that the global epidemic of severe acute res- ratory syndrome (SARS) in 2002-2003 was caused by a newly discovered coronavirus called SARS-CoV. A record 225 scientists from 14 countries attended the Xth International Nidovirus Symposium, and important advances in every aspect of nidovirus molecular biology and pathogenesis were reported and discussed. The meeting was divided into 12 sessions, with keynote speakers providing a general review of research pertinent to each one. This volume is a collection of scientific papers presented at the symposium. Once a coronavirus was recognized as the etiological agent of SARS, intensive work by many investigators resulted in determination of the sequence of the virus, engineering of reverse genetics systems, and identification of the host cell receptor used by the virus. With the increased interest in coronaviruses, new members of the family associated with human disease were identified.


Table of Contents

John ZiebuhrLuis Enjuanes and Fernando Almazán and Isabel Sola and Sonia Zúñiga and Enrique Alvarez and Juan Reguera and Carmen CapiscolPinghua Liu and Jason J. Millership and Lichun Li and David P. Giedroc and Julian L. LeibowitzSonia Zúñiga and Isabel Sola and Jose L. Moreno and Sara Alonso and Luis EnjuanesNaina Barretto and Dalia Jukneliene and Kiira Ratia and Zhongbin Chen and Andrew D. Mesecar and Susan C. BakerBarbara Schelle and Nadja Karl and Burkhard Ludewig and Stuart G. Siddell and Volker ThielRajesh Ponnusamy and Jeroen R. Mesters and John Ziebuhr and Ralf Moll and Rolf HilgenfeldLance D. Eckerle and Sarah M. Brockway and Steven M. Sperry and Xiaotao Lu and Mark R. DenisonEric F. Donaldson and Amy C. Sims and Damon J. Deming and Ralph S. BaricRachel L. Graham and Amy C. Sims and Ralph S. Baric and Mark R. DenisonKay S. Faaberg and Jun Han and Yue WangCarmen Galán and Luis Enjuanes and Fernando AlmazánSnawar Hussain and Ji'an Pan and Jing Xu and Yalin Yang and Yu Chen and Yu Peng and Ying Wu and Zhaoyang Li and Ying Zhu and Po Tien and Deyin GuoXiao X. Wang and Ying Liao and Sek M. Wong and Ding X. LiuÁkos Putics and Jutta Slaby and Witold Filipowicz and Alexander E. Gorbalenya and John ZiebuhrYvonne Piotrowski and Lia van der Hoek and Krzysztof Pyrc and Ben Berkhout and Ralf Moll and Rolf HilgenfeldDamon J. Deming and Rachel L. Graham and Mark R. Denison and Ralph S. BaricHyojeung Kang and Min Feng and Meagan E. Schroeder and David P. Giedroc and Julian L. LeibowitzSoonjeon Youn and Ellen W. Collisson and Carolyn E. MachamerAndrew Pekosz and Scott R. Schaecher and Michael S. Diamond and Daved H. Fremont and Amy C. Sims and Ralph S. BaricQisheng Li and Han Xiao and James P. Tam and Ding X. LiuValerie Bednar and Sandhya Verma and Andrew Blount and Brenda G. HogueKelly-Anne Spencer and Julian A. HiscoxJohn Bechill and Zhongbin Chen and Joseph W. Brewer and Susan C. BakerChanghee Lee and Douglas C. Hodgins and Jay G. Calvert and Siao-Kun Wan Welch and Rika Jolie and Dongwan YooMatthew B. Frieman and Boyd Yount and Amy C. Sims and Damon J. Deming and Thomas E. Morrison and Jennifer Sparks and Mark Denison and Mark Heise and Ralph S. BaricYing Fang and Andrew Pekosz and Lia Haynes and Eric A. Nelson and Raymond R. R. RowlandTiana C. White and Brenda G. HoguePaul S. Masters and Lili Kuo and Rong Ye and Kelley R. Hurst and Cheri A. Koetzner and Bilan HsueAna Garzón and Ana M. Maestre and Jaime Pignatelli and M. Teresa Rejas and Dolores RodríguezBenjamin W. Neuman and Brian D. Adair and Craig Yoshioka and Joel D. Quispe and Ronald A. Milligan and Mark Yeager and Michael J. BuchmeierYe Ye and Brenda G. HogueCarolyn E. Machamer and Soonjeon YounYing Liao and James P. Tam and Ding X. LiuKlara K. Eriksson and Divine Makia and Reinhard Maier and Luisa Cervantes and Burkhard Ludewig and Volker ThielWenhui Li and Hyeryun Choe and Michael FarzanHeike Hofmann and Andrea Marzi and Thomas Gramberg and Martina Geier and Krzysztof Pyrc and Lia van der Hoek and Ben Berkhout and Stefan PöhlmannFang Li and Wenhui Li and Michael Farzan and Stephen C. HarrisonGraham Simmons and Andrew J. Rennekamp and Paul BatesVictor C. Chu and Lisa J. McElroy and Beverley E. Bauman and Gary R. WhittakerPeter L. Delputte and H. J. NauwynckShutoku Matsuyama and Makoto Ujike and Koji Ishii and Shuetsu Fukushi and Shigeru Morikawa and Masato Tashiro and Fumihiro TaguchiLaura Gillim-Ross and Lindsay K. Heller and Emily R. Olivieri and David E. WentworthScott A. Jeffers and Erin M. Hemmila and Kathryn V. HolmesChristel Schwegmann-Weβels and Xiaofeng Ren and Georg HerrlerEmily R. Olivieri and Lindsey K. Heller and Laura Gillim-Ross and David E. WentworthStefan Pöhlmann and Thomas Gramberg and Anja Wegele and Krzysztof Pyrc and Lia van der Hoek and Ben Berkhout and Heike HofmannM. K. Smith and Sonia Tusell and Emily A. Travanty and Ben Berkhout and Lia van der Hoek and Kathryn V. HolmesSonia M. Tusell and Kathryn V. HolmesShuetsu Fukushi and Tetsuya Mizutani and Masayuki Saijo and Shutoku Matsuyama and Fumihiro Taguchi and Ichiro Kurane and Shigeru MorikawaLisa A. Lopez and Ariel Jones and William D. Arndt and Brenda G. HogueWillie C. McRoy and Ralph S. BaricJoseph A. Boscarino and Jeffrey M. Goletz and Thomas M. GallagherVictor C. Chu and Lisa J. Mcelroy and A. Damon Ferguson and Beverley E. Bauman and Gary R. WhittakerJae-Hwan You and Mark L. Reed and Brian K. Dove and Julian A. HiscoxMegan W. Howard and Brian Tripet and Michael G. Jobling and Randall K. Holmes and Kathryn V. Holmes and Robert S. HodgesTetsuya Mizutani and Shuetsu Fukushi and Masayuki Saijo and Ichiro Kurane and Shigeru MorikawaKeiko Nakagaki and Kazuhide Nakagaki and Fumihiro TaguchiRie Watanabe and Kazumitsu Suzuki and Fumihiro TaguchiI-Chueh Huang and Berend Jan Bosch and Wenhui Li and Michael Farzan and Peter M. Rottier and Hyeryun ChoeCornelia C. Bergmann and Chandran Ramakrishna and J. M. Gonzales and S.I. Tschen and Stephan A. StohlmanTanya A. Miura and Jieru Wang and Robert J. Mason and Kathryn V. HolmesBrian K. Dove and Katrina Bicknell and Gavin Brooks and Sally Harrison and Julian A. HiscoxPaul Britton and Rosa Casais and Teri Hodgson and Marc Davis and Dave CavanaghKevin B. Walsh and Melissa B. Lodoen and Lewis L. Lanier and Thomas E. LaneNadine DeAlbuquerque and Ehtesham Baig and Max Xuezhong and Itay Shalev and M. James Phillips and Marlena Habal and Julian Leibowitz and Ian McGilvray and Jagdish Butany and Eleanor Fish and Gary LevyYin Liu and Xuming ZhangKatherine C. MacNamara and Susan R. WeissNorio Hirano and Hideharu Taira and Shigehiro Sato and Tsutomu Hashikawa and Koujiro TohyamaSusan C. Baker and Dalia Jukneliene and Anjan Purkayastha and Eric E. Snyder and Oswald R. Crasta and Michael J. Czar and Joao C. Setubal and Bruno W. SobralRenaud Burrer and Matthias G. von Herrath and Tom Wolfe and Julia D. Rempel and Antonio Iglesias and Michael J. BuchmeierMara Battilani and Ambra Foschi and Alessandra Scagliarini and Sara Ciulli and Santino Prosperi and Luigi MorgantiDongdong Yu and Xuming ZhangHaixia Zhou and Stanley PerlmanSonia Navas-Martín and Maarten Brom and Susan R. WeissHao Liu and Li Zhang and Myron Cybulsky and Reg Gorczynski and Jennifer Crookshank and Justin Manuel and David Grant and Gary LevyN. James MacLachlan and Udeni B. BalasuriyaSusan K. Schommer and Steven B. KleiboekerAndrei Musaji and Dominique Markine-Goriaynoff and Stéphanie Franquin and Gaëtan Thirion and Thao Le Thi Phuong and Jean-Paul CoutelierJun Han and Kelly M. Burkhart and Eric M. Vaughn and Michael B. Roof and Kay S. FaabergGerald Misinzo and Peter L. Delputte and Peter Meerts and Christa Drexler and Hans J. NauwynckLeo L. M. PoonAnjeanette Roberts and Kanta SubbaraoHélène Jacomy and Pierre J. TalbotHong Peng Jia and Dwight C. Look and Melissa Hickey and Lei Shi and Lecia Pewe and Jason Netland and Michael Farzan and Christine Wohlford-Lenane and Stanley Perlman and Paul B. McCray, Jr.Lia van der Hoek and Klaus Sure and Gabriele Ihorst and Alexander Stang and Krzysztof Pyrc and Maarten F. Jebbink and Gudula Petersen and Johannes Forster and Ben Berkhout and Klaus ÜberlaLecia Pewe and Haixia Zhou and Jason Netland and Chandra Tangadu and Heidi Olivares and Lei Shi and Dwight Look and Thomas Gallagher and Stanley PerlmanJulien R. St-Jean and Marc Desforges and Pierre J. TalbotEric C. Mossel and Bruno Sainz, Jr. and Robert F. Garry and C.J. PetersLindsay K. Heller and Laura Gillim-Ross and Emily R. Olivieri and David E. WentworthMarc Desforges and Tina Miletti and Mylène Gagnon and Pierre J. TalbotNoriyo Nagata and Naoko Iwata and Hideki Hasegawa and Yasuko Asahi-Ozaki and Yuko Sato and Ayako Harashima and Shigeru Morikawa|cMasayuki Saijo and Shigeyuki Itamura and Takehiko Saito and Takato Odagiri and Masato Tashiro and Yasushi Ami and Tetsutaro SataAya Zamoto and Fumihiro Taguchi and Shuetsu Fukushi and Shigeru Morikawa and Yasuko K. YamadaS.C. Baker and C. Shimizu and H. Shike and F. Garcia and L. van der Hoek and T.W. Kuijper and S.L. Reed and A.H. Rowley and S.T. Shulman and H.K.B. Talbot and J.V. Williams and J.C. BurnsHongqing Zhu and Yin Liu and Yingyun Cai and Dongdong Yu and Yinghui Pu and Laura Harmon and Xuming ZhangNoah Butler and Lecia Pewe and Kathryn Trandem and Stanley PerlmanAmy C. Sims and Boyd Yount and Susan E. Burkett and Ralph S. Baric and Raymond J. PicklesYuxian HeKaren E. Malone and Chandran Ramakrishna and J.-M. Gonzalez and Stephan A. Stohlman and Cornelia C. BergmannTimothy Sheahan and Damon Deming and Eric Donaldson and Raymond Pickles and Ralph BaricRalph S. Baric and Timothy Sheahan and Damon Deming and Eric Donaldson and Boyd Yount and Amy C. Sims and Rhonda S. Roberts and Matthew Frieman and Barry RockxMasaji Okada and Yuji Takemoto and Yoshinobu Okuno and Satomi Hashimoto and Yukari Fukunaga and Takao Tanaka and Yoko Kita and Sechiko Kuwayama and Yumiko Muraki and Noriko Kanamaru and Hiroko Takai and Chika Okada and Yayoi Sakaguchi and Izumi Furukawa and Kyoko Yamada and Miwa Izumiya and Shigeto Yoshida and Makoto Matsumoto and Tetsuo Kase and J.S.M. Peiris and Daphne E. deMello and Pei-Jer Chen and Naoki Yamamoto and Yoshiyuki Yoshinaka and Tatsuji Nomura and Isao Ishida and Shigeru Morikawa and Masato Tashiro and Mitsunori SakataniBenjamin W. Neuman and David A. Stein and Andrew D. Kroeker and Hong M. Richard and K. Bestwick and Patrick L. Iversen and Michael J. BuchmeierLauren Wilson and Peter Gage and Gary EwartFernando Almazán and Marta L. De Diego and Carmen Galán and Enrique Álvarez and Luis EnjuanesRolf Hilgenfeld and Kanchan Anand and Jeroen R. Mesters and Zihe Rao and Xu Shen and Hualiang Jiang and Jinzhi Tan and Koen H.G. VerschuerenKoji Ishii and Hideki Hasegawa and Noriyo Nagata and Tetsuya Mizutani and Shigeru Morikawa and Masato Tashiro and Tetsuro Suzuki and Fumihiro Taguchi and Toshitada Takemori and Tatsuo Miyamura and Yasuko Tsunetsugu-YokotaRhonda S. Roberts and Boyd L. Yount and Amy C. Sims and Susan Baker and Ralph S. BaricNorio Hirano and Takenori NakayamaYing Fang and Kay S. Faaberg and Raymond R.R. Rowland and J. Christopher-Hennings and Asit K. Pattnaik and Fernando Osorio and Eric A. NelsonElke Scandella and Klara K. Eriksson and Tobias Hertzig and Christian Drosten and Lili Chen and Chunshan Gui and Xiaomin Luo and Jianhua Shen and Xu Shen and Stuart G. Siddell and Burkhard Ludewig and Hualiang Jiang and Stephan Günther and Volker Thiel
I Viral RNA Synthesis
1.1 The Coronavirus Replicase: Insights into a Sophisticated Enzyme Machineryp. 3
1.2 Biochemical Aspects of Coronavirus Replicationp. 13
1.3 A Previously Unrecognized UNR Stem-Loop Structurein the Coronavirus 5' Untranslated Region Plays a Functional Role in Replicationp. 25
1.4 Regulation of Coronavirus Transcription: Viral and Cellular Proteins Interacting with Transcription-Regulating Sequencesp. 31
1.5 Deubiquitinating Activity of the SARS-CoV Papain-Like Proteasep. 37
1.6 Nucleocapsid Protein Expression Facilitates Coronavirus Replicationp. 43
1.7 Non Structural Proteins 8 and 9 of Human Coronavirus 229Ep. 49
1.8 Effects of Mutagenesis of Murine Hepatitis Virus NSP1 and NSP14 on Replication in Culturep. 55
1.9 Mutational Analysis of MHV-A59 Replicase Protein-NSP10p. 61
1.10 The NSP2 Proteins of Mouse Hepatitis Virus and SARS Coronavirus are Dispensable for Viral Replicationp. 67
1.11 Molecular Dissection of Porcine Reproductive and Respiratory Virus Putative Nonstructural Protein 2p. 73
1.12 Differential Role of N-Terminal Polyprotein Processing in Coronavirus Genome Replication and Minigenome Amplificationp. 79
1.13 Identification and Characterization of Severe Acute Respiratory Syndrome Coronavirus Subgenomic RNAsp. 85
1.14 Identification and Characterization of a Unique Ribosomal Frameshifting Signal in SARS-CoV ORF3Ap. 89
1.15 ADP-Ribose-1″-Phosphatase Activities of the Human Coronavirus 229E and SARS Coronavirus X Domainsp. 93
1.16 Nonstructural Proteins of Human Coronavirus NL63p. 97
1.17 MHV-A59 ORF1A Replicase Protein NSP7-NSP10 Processing in Replicationp. 101
1.18 Stem-loop 1 in the 5' UTR of the SARS Coronaviruscan Substitute for its Counterpart in Mouse Hepatitis Virusp. 105
1.19 Transcriptional Regulation of RNA3 of Infectious Bronchitis Virusp. 109
II Protein Synthesis, Structure, and Processing
2.1 Structure, Expression, and Intracellular Localization of the SARS-CoV Accessory Proteins 7a and 7bp. 115
2.2 Sumoylation of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus by Interaction with UBC9p. 121
2.3 Importance of MHV-CoV A59 Nucleocapsid Protein COOH-Terminal Negative Chargesp. 127
2.4 Expression and Structural Analysis of Infectious Bronchitis Virus Nucleoproteinp. 133
2.5 Mouse Hepatitis Virus Infection Activates the IRE1/XBP1 Pathway of the Unfolded Protein Responsep. 139
2.6 The Nuclear Localization Signal of the PRRS Virus Nucleocapsid Protein Modulates Viral Replication in vitro and Antibody Response in vivop. 145
2.7 SARS Coronavirus Accessory ORFs Encode Luxury Functionsp. 149
2.8 Production and Characterization of Monoclonal Antibodies Against the Nucleocapsid Protein of SARS-COVp. 153
2.9 Mouse Hepatitis Coronavirus Nucleocapsid Phosphorylationp. 157
III Viral Assembly and Release
3.1 Genetic and Molecular Biological Analysis of Protein-Protein Interactions in Coronavirus Assemblyp. 163
3.2 New Insights on the Structure and Morphogenesis of Berne Virusp. 175
3.3 Ultrastructure of SARS-CoV, FIPV, and MHV Revealed by Electron Cryomicroscopyp. 181
3.4 Role of Mouse Hepatitis Coronavirus Envelope Protein Transmembrane Domainp. 187
3.5 The Transmembrane Domain of the Infectious Bronchitis Virus E Protein is Required for Efficient Virus Releasep. 193
3.6 Viroporin Activity of SARS-CoV E Proteinp. 199
3.7 Efficient Transduction of Dendritic Cells using Coronavirus-based Vectorsp. 203
IV Viral Entry
4.1 Insights from the Association of SARS-CoV S-Protein with its Receptor, ACE2p. 209
4.2 Attachment Factor and Receptor Engagement of SARS Coronavirus and Human Coronavirus NL63p. 219
4.3 Interactions between SARS Coronavirus and its Receptorp. 229
4.4 Proteolysis of SARS-Associated Coronavirus Spikeglycoproteinp. 235
4.5 Fluorescence Dequenching Assays of Coronavirus Fusionp. 241
4.6 Porcine Arterivirus Entry in Macrophages: Heparan Sulfate - Mediated Attachment, Sialoadhesin-mediated Internalization, and a Cell-Specific Factor Mediating Virus Disassembly and Genome Releasep. 247
4.7 Enhancement of SARS-CoV Infection by Proteasesp. 253
4.8 Increased Viral Titers and Subtle Changes in Plaquemorphology upon Passage of SARS-CoV in Cells from Different Speciesp. 259
4.9 Human Coronavirus 229E can use CD209L (L-sign) to Enter Cellsp. 265
4.10 Intracellular Transport of the S Proteins of Coronavirusesp. 271
4.11 Analysis of SARS-CoV Receptor Activity of ACE2 Orthologsp. 277
4.12 Interaction between the Spike Protein of Human Coronavirus NL63 and its Cellular Receptor ACE2p. 281
4.13 Human Angiotensin - Converting Enzyme 2 (ACE2) is a Receptor for Human Respiratory Coronavirus NL63p. 285
4.14 Molecular Interactions of Group 1 Coronaviruses with Feline APNp. 289
4.15 Pseudotyped Vesicular Stomatitis Virus for Functional Analysis of SARS Coronavirus Spike Proteinp. 293
4.16 Subcellular Localization of SARS-CoV Structural Proteinsp. 297
4.17 Spike Gene Determinants of Mouse Hepatitis Virus Host Range Expansionp. 301
4.18 Virion-liposome Interactions Identify a Cholesterol-Independent Coronavirus Entry Stagep. 305
4.19 Avian Infectious Bronchitis Virus Enters Cells via the Endocytic Pathwayp. 309
4.20 Three-dimensional Reconstruction of the Nucleolus using Meta-Confocal Microscopy in Cells Expressing the Coronavirus Nucleoproteinp. 313
4.21 Dissection of the Fusion Machine of SARS-Coronavirusp. 319
4.22 Characterization of Persistent SARS-CoV Infection in Vero E6 Cellsp. 323
4.23 Receptor-independent Spread of a Neurotropic Murine Coronavirus MHV-JHMV in Mixed Neural Culturep. 327
4.24 Receptor-Independent Infection of Mouse Hepatitis Virus: Analysis by Spinoculationp. 331
4.25 SARS-CoV, but not HCoV-NL63, Utilizes Cathepsins to Infect Cells: Viral Entryp. 335
V Pathogenesis of Non-human Coronaviruses
5.1 Coronavirus Immunity: From T Cells to B Cellsp. 341
5.2 Rat Coronavirus Infection of Primary Rat Alveolar Epithelial Cellsp. 351
5.3 Infectious Bronchitis Coronavirus Induces Cell-Cycle Perturbationsp. 357
5.4 Genes 3 and 5 of Infectious Bronchitis Virus are Accessory Protein Genesp. 363
5.5 NKG2D Signaling and Host Defense after Mouse Hepatitisvirus Infection of the Central Nervous Systemp. 369
5.6 Murine Hepatitis Virus Strain 1 as a Model for Severe Acute Respiratory Distress Syndrome (SARS)p. 373
5.7 Persistent Coronavirus Infection of Progenitor Oligodendrocytesp. 379
5.8 CD8+ T-Cell Priming During a Central Nervous System Infection with Mouse Hepatitis Virusp. 385
5.9 Antibody-mediated Virus Clearance from Neurons of Rats Infected with Hemagglutinating Encephalomyelitis Virusp. 391
5.10 Developing Bioinformatic Resources for Coronavirusesp. 395
5.11 Autoantibodies Exacerbate the Severity of MHV-Induced Encephalitisp. 399
5.12 Analysis of the N Protein in Feline Coronavirus Strains in Italyp. 403
5.13 Differential Induction of Proinflammatory Cytokines in Primary Mouse Astrocytes and Microglia by Coronavirus Infectionp. 407
5.14 Preferential Infection of Mature Dendritic Cells by the JHM Strain of Mouse Hepatitis Virusp. 411
5.15 Role of the Replicase Gene of Murine Coronavirus JHM Strain in Hepatitisp. 415
5.16 Identification of the Receptor for FGL2 and Implications for Susceptibility to Mouse Hepatitis Virus (MHV-3)-Induced Fulminant Hepatitisp. 421
VI Pathogenesis of Arteriviruses and Toroviruses
6.1 Equine Viral Arteritisp. 429
6.2 Use of a PRRSV Infectious Clone to Evaluate in Vitro Quasispecies Evolutionp. 435
6.3 Gamma-Interferon Involvement in the Pathogenesis of Lactate Dehydrogenase-Elevating Virus Infectionp. 439
6.4 Replication and Expression Analysis of PRRSV Defective RNAp. 445
6.5 Efficacy of an Inactivated PRRSV Vaccine: Induction of Virus-Neutralizing Antibodies and Partial Virological Protection upon Challengep. 449
VII Pathogenesis of Human Coronaviruses
7.1 SARS and Other Coronaviruses in Humans and Animalsp. 457
7.2 Animal Models for SARSp. 463
7.3 HCoV-OC43-Induced Apoptosis of Murine Neuronal Cellsp. 473
7.4 Infection of Human Airway Epithelia by SARS Coronavirus is Associated with ACE2 Expression and Localizationp. 479
7.5 Human Coronavirus NL63 Infection is Associated with Croupp. 485
7.6 A SARS-CoV-Specific Protein Enhances Virulence of an Attenuated Strain of Mouse Hepatitis Virusp. 493
7.7 Genetic Evolution of Human Coronavirus OC43 in Neural Cell Culturep. 499
7.8 Synergistic Inhibition of SARS-Coronavirus Replication by Type I and Type II IFNp. 503
7.9 Mustela Vison ACE2 Functions as a Receptor for SARS-Coronavirusp. 507
7.10 HCoV-229E Infects and Activates Monocytesp. 511
7.11 Pathological and Virological Analyses of Severe Acute Respiratory Syndrome-associated Coronavirus Infections in Experimental Animalsp. 515
7.12 Identification of Ferret ACE2 and its Receptor Function for SARS-Coronavirusp. 519
7.13 Human Coronavirus-NL63 Infection is not Associated with Acute Kawasaki Diseasep. 523
7.14 Toward the Development of an Infectious cDNA Clone of a Human Enteric Coronavirusp. 527
7.15 HCoV-OC43-Induced Encephalitis is in Part Immune-Mediatedp. 531
7.16 SARS CoV Replication and Pathogenesis in Human Airway Airway Epithelial Culturesp. 535
7.17 Immunogenicity of SARS-CoV: The Receptor-Binding Domain of S Protein is a Major Target of Neutralizing Antibodiesp. 539
7.18 Glia Expression of MHC During CNS Infection by Neurotropic Coronavirusp. 543
7.19 Resurrection of an ""Extinct"" SARS-CoV Isolate GD03 from Late 2003p. 547
VIII Vaccines, Antiviral Drugs, and Diagnostics
8.1 SARS Coronavirus Vaccine Developmentp. 553
8.2 Development of Vaccines and Passive Immunotherapy Against SARS Coronavirus using Mouse and SCID-PBL/hu Mouse Modelsp. 561
8.3 Inhibition and Escape of SARS-CoV Treated with Antisense Morpholino Oligomersp. 567
8.4 Validation of Coronavirus E Proteins Ion Channels as Targets for Antiviral Drugsp. 573
8.5 Identification of Essential Genes as a Strategy to Select a SARS Candidate Vaccine using a SARS-CoV Infectious cDNAp. 579
8.6 Structure and Dynamics of SARS Coronavirus Main Proteinase (M PRO )p. 585
8.7 Highly Attenuated Vaccinia Virus DIs as a Potential SARS Vaccinep. 593
8.8 Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of Anti-SARS-CoV Agentsp. 597
8.9 Virucidal Effect of a Newly Developed Nickel Alloy on Mouse Coronavirusp. 601
8.10 Construction of a Full-length CDNA Infectious Clone of a European-like Type 1 PRRSV Isolated in the U.Sp. 605
8.11 Identification and Evaluation of Coronavirus Replicase Inhibitors using a Replicon Cell Linep. 609
Indexp. 615